Moly crisis to continue as AECL pushes reactor restart to 2010

Aug 12, 2009

Nuclear medicine physicians may have to wait a little longer for the shortage of the radioisotope molybdenum-99 to abate. Atomic Energy of Canada (AECL) has pushed back the anticipated restart of its Chalk River, Ontario, nuclear reactor to the first quarter of 2010.

Click here to read the rest of the article.

Latest in Nuclear Medicine
Healthcare professional in white coat speaking with older man wearing glasses in casual conversation
What are patients being told before, during, and after Lu-177 RPT?
November 5, 2026
Multi-panel PET-CT and CT brain imaging scans showing axial and coronal views with metabolic activity overlay
Lu-177 FAP-2286 controls lung cancer brain metastases
November 4, 2026
See how one team is getting more from SPECT/CT
Sponsored
See how one team is getting more from SPECT/CT
November 2, 2026
Professional headshot of an Asian man in white shirt and dark tie, smiling at camera against gray background
Jeremie Calais discusses his move to Paris, European research
November 2, 2026
Related Stories
2009 08 12 13 36 02 745 Pet Market Siemens Thumb
Nuclear Medicine
U.S. PET sales drop 17% in 2008, but optimism remains
2009 07 31 14 50 21 466 2009 08 03 Neuroblast Thumb
Nuclear Medicine
FDG-PET best for early detection of neuroblastoma
2009 07 29 11 16 21 770 Hacker Image01 Thumb
Nuclear Medicine
Dual-source CTA turns in mixed results for coronary stenoses
See how one team is getting more from SPECT/CT
Sponsor Content
See how one team is getting more from SPECT/CT
More in Nuclear Medicine
What are patients being told before, during, and after Lu-177 RPT?
By Will Morton
The recommended duration for maintaining distance from others after treatment ranged from one to three days at some sites and up to seven days at others.
November 5, 2026
Healthcare professional in white coat speaking with older man wearing glasses in casual conversation
Lu-177 FAP-2286 controls lung cancer brain metastases
By Will Morton
Brain metastasis from advanced lung cancer represents a formidable clinical challenge, primarily due to the protective blood brain barrier.
November 4, 2026
Multi-panel PET-CT and CT brain imaging scans showing axial and coronal views with metabolic activity overlay
UW-Madison breaks ground on $62M cyclotron facility
By AuntMinnie.com staff writers
The 13,000-square-foot facility, inside the existing Wisconsin Institutes for Medical Research complex, will house two new cyclotrons.
November 2, 2026
Modern hospital building complex with contemporary architecture, glass facades, and landscaped grounds under blue sky
Jeremie Calais discusses his move to Paris, European research
By Will Morton
The move was driven primarily by family (it is a return home for him and his wife) but it closes a chapter that reshaped nuclear medicine in the U.S.
November 2, 2026
Professional headshot of an Asian man in white shirt and dark tie, smiling at camera against gray background
Eckert & Ziegler gets GMP manufacturing authorization for Ac-225
By AuntMinnieEurope.com staff writers
The firm is also planning Ac-225 production at its joint venture facility in China and further expansion in the U.S. and Germany.
October 28, 2026
Scientific illustration showing chemical formulas, molecular structures, and atomic models on purple gradient background
AdvanCell reports data on Pb-212 PSMA therapy
By AuntMinnie.com staff writers
Eighty percent of patients had a prostate-specific antigen (PSA) decline of at least 50%, according to the company.
October 26, 2026
Medical illustration of prostate gland surrounded by red cancer cells on blue background
EANM: Is ‘research fragmentation’ holding back nuclear medicine?
By Will Morton
Well-designed studies require collaboration among nuclear medicine, medical oncology, urology, radiation oncology, and clinical trial support.
October 21, 2026
Research presentation on nuclear medicine fragmentation showing 25 studies with PET imaging criteria analysis and expert interview
Telix posts revenue growth in Q3
By AuntMinnie.com staff writers
For the period (end-September 30), Telix had group revenues of $245 million, up from $206 million in the same period last year.
October 21, 2026
Business analyst examining financial data charts and percentages through magnifying glass on laptop screen
EANM: Thomas Hope on what’s next in FAP-targeted theranostics
By Will Morton
The innovations and work being done to optimize FAP agents will likely "spill over" to other targets.
October 19, 2026
Clinical research presentation slide showing FAP RLT experience data table with patient outcomes across multiple institutions and speaker photo
Nuclidium, NorthStar sign Cu-67 supply and manufacturing deal
By AuntMinnie.com staff writers
Cu-67 is the therapeutic half of Nuclidium’s theranostic platform, which pairs it with copper-61 (Cu-61) for diagnostic imaging.
October 19, 2026
Hand holding glowing atom symbol with blue and gold light effects against blurred tech background
Capitol Imaging Services acquires Impression Imaging
By AuntMinnie.com staff writers
CIS said the deal is part of its expansion into molecular imaging and theranostics.
October 16, 2026
Two businessmen in suits shaking hands during a professional meeting
AtomVie, Jubilant Radiopharma enter distribution partnership
By AuntMinnie.com staff writers
Jubilant will handle receipt, regulatory compliance, and distribution of AtomVie-manufactured radiopharmaceuticals.
October 15, 2026
Digital handshake with blue and orange technology network patterns symbolizing business partnership and innovation
Page 1 of 446
Next Page